Drug/Chemo Combination Has Benefits

Published Online: Friday, July 1, 2005

Two drug trials sponsored by the US Department of Health and Human Services have determined that the drug trastuzumab (Herceptin) used in combination with chemotherapy can cut the risk of a recurrence of HER-2 breast cancer. The 2 trials included more than 3300 women receiving Herceptin along with standard chemotherapy. The results showed a 52% decrease in the recurrence of breast cancer, compared with chemotherapy treatment alone.

Thirty percent of the estimated 211,240 cases of breast cancer diagnosed in the United States each year are related to an overabundance of the HER-2 protein on the surface of the cancer cells. These particular tumors have a likelihood of recurring and growing rapidly. National Cancer Institute Director Andrew von Eschenbach, MD, remarked that the findings of these trials are "a major advance for many thousands of women with breast cancer."



Latest Articles
Pharmacists might be surprised to learn that Pinterest is a hotbed for anti-vaccine sentiment.
The FDA has approved betamethasone dipropionate spray, 0.05%, as a treatment for mild to moderate plaque psoriasis in patients aged 18 years and older.
Medication errors injure thousands of patients annually, and while mistakes occur with all medication classes, those involving antiretroviral therapies are particularly troublesome.
Acute respiratory infections such as the common cold are often accompanied by cough and congestion caused by mucus hypersecretion.
Latest Issues
$auto_registration$
VSEO N/A